Bioavailability of buserelin and gonadorelin in suspensions
Dolińska, B.; Ryszka, F.; Szulc, B.
Bollettino Chimico Farmaceutico 134(8): 459-460
1995
ISSN/ISBN: 0006-6648 PMID: 7576445 Document Number: 451102
There have been determined parameters defining biological availability of gonadorelin and buserelin marked 125 J. Hormonal preparations were hypodermically administered to the rats in suspensions containing zinc ions of the molar ratio of the hormone: zinc 1:5. It has been stated that buserelin in suspension is better available to an organism than gonadorelin .
Document emailed within 1 workday
Related Documents
Günther, C.; Truckenbrodt, J.; Traeger, A. 1987: The relative bioavailability of co-trimoxazole suspensions Die Pharmazie 42(6): 397-399Rambhau, D.; Gudsoorkar, V.R.; Rao, Y.M. 1983: Bioavailability of sulfathiazole from flocculated and deflocculated suspensions and its implications Indian Journal of Physiology and Pharmacology 27(3): 217-220
Pace, J.N.; Miller, J.L.; Rose, L.I. 1991: GnRH agonists: gonadorelin, leuprolide and nafarelin American Family Physician 44(5): 1777-1782
Firsov, A.A.; Piotrovskii, V.K. 1986: Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability Die Pharmazie 41(7): 457-465
Fenichel, P.; Grimaldi, M.; Greck, T.; Benoit, B.; Fiorentini, M.; Tran, D.K.; Gillet, J.Y.; Harter, M. 1986: Hypophyseal blockage by a gonadorelin analogue, D-Trp6-LHRH retard, to improve induction of ovulation Presse Medicale 15(43): 2167
Simonin, R.; Nicolino-Peltier, C.; Gainlet, P. 1989: Gonadorelin analogs combined with anti-androgens in the treatment of bone metastasis from prostate cancer. can their use induce osteoporosis? Presse Medicale 18(41): 2023
Chen, S.C.; Ng, H.T.; Tzeng, C.R.; Chao, H.T.; Chang, S.P.; Wei, T.C.; Yang, T.S. 1991: Buserelin treatment of endometriosis in Chinese women Zhonghua Yi Xue Za Zhi 47(1): 1-6
Choktanasiri, W.; Rojanasakul, A. 2001: Buserelin acetate implants in the treatment of pain in endometriosis Journal of the Medical Association of Thailand 84(5): 656-660
Heberal, A.; Batioglu, S.; Celikkanat, H. 1996: The adjuvant effect of oxytocin on GnRH analogue buserelin Jpma. Journal of the Pakistan Medical Association 46(6): 134-135
Brogden, R.N.; Buckley, M.M.; Ward, A. 1990: Buserelin. a review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Drugs 39(3): 399-437
Huang, F.J.; Kung, F.T.; Chang, S.Y.; Hsu, T.Y. 1999: Effects of short-course buserelin therapy on adenomyosis. A report of two cases Journal of Reproductive Medicine 44(8): 741-744
Wenderoth, U.K.; Jacobi, G.H. 1986: Treatment of advanced cancer of the prostate with an analog of LHRH, buserelin Annales d'Urologie 20(2): 95-97
Chang, M.Y.; Tsai, F.B.; Soong, Y.K. 1993: Infarcted intramural uterine leiomyomata during buserelin acetate treatment Changgeng Yi Xue Za Zhi 16(2): 129-132
Schumacher, T.; Zwirner, M.; Unterberg, H.; Pohl, C.; Keller, E.; Schindler, A.E. 1984: Effects of the lhrh analog buserelin given discontinuously as a contraceptive on ovarian cycle and lipometabolism Neuro Endocrinology Letters 6(5): 267-272
Ueda, K.; Sawasaki, T.; Nakaoka, Y.; Takehara, K.; Ohama, K. 1993: Two cases of hypovolemic shock by massive bleeding associated with submucous leiomyoma during buserelin treatment Nihon Sanka Fujinka Gakkai Zasshi 45(12): 1417-1420
Dawood, M.Y.; Spellacy, W.N.; Dmowski, W.P.; Gambrell, R.D.; Greenblatt, R.B.; Girard, Y.; Lemay, A.; Mishell, D.R.; Nagamani, M.; Pepperell, R.J. 1990: A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group Progress in Clinical and Biological Research 323: 253-267
Debruyne, F.M.; Karthaus, H.F.; Schröder, F.H.; de Voogt, H.J.; de Jong, F.H.; Klijn, J.G. 1985: Results of a Dutch Phase Ii trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer Progress in Clinical and Biological Research 185a: 251-270
Nisolle, M.; Clerckx, F.; Casanas-Roux, F.; Gillerot, S.; Bourgonjon, D.; Donnez, J. 1990: Treatment of endometriosis. Evaluation of preoperative therapy with danazol, gestrinone and buserelin (nasal spray and implant) Journal de Gynecologie Obstetrique et Biologie de la Reproduction 19(6): 759-763
Reznik, Y.; Winiger, B.P.; Aubert, M.L.; Sizonenko, P.C. 1987: Pharmacodynamics of [D-Ser (t-Bu)6,Des-Gly10]GnRH ethylamide (Buserelin) in 6 normal volunteers. its usefulness to monitor treatment of central precocious puberty Acta Endocrinologica 115(2): 235-242
De Voogt, H.J.; Adenauer, H.; Widdra, W.G. 1991: The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. a 10-year review on 1522 patients treated in 119 centres on 4 continents Scandinavian Journal of Urology and Nephrology. Supplementum 138: 131-136